AAPL343.75+1.75 (+0.51%) ▲|ABBV284.01+0.66 (+0.23%) ▲|ABT105.38+0.70 (+0.67%) ▲|ACN225.52+0.60 (+0.27%) ▲|ADBE249.76-1.91 (-0.76%) ▼|AMAT421.43-8.58 (-2.00%) ▼|AMD542.63-19.61 (-3.49%) ▼|AMGN437.85+3.82 (+0.88%) ▲|AMT183.39+2.03 (+1.12%) ▲|AMZN253.21-1.55 (-0.61%) ▼|AVGO338.43-5.91 (-1.71%) ▼|AXP319.10+5.23 (+1.67%) ▲|BA191.52+2.79 (+1.48%) ▲|BAC52.32+0.62 (+1.20%) ▲|BKNG166.32+0.52 (+0.31%) ▲|BLK1,139.18+18.40 (+1.64%) ▲|BMY60.81+0.24 (+0.39%) ▲|BNY143.80+1.71 (+1.20%) ▲|BRK-B531.42+5.74 (+1.09%) ▲|C125.85+2.64 (+2.14%) ▲|CAT738.06+2.42 (+0.33%) ▲|CL93.65+0.98 (+1.06%) ▲|CMCSA22.08+0.31 (+1.42%) ▲|COF203.55+4.69 (+2.36%) ▲|COP144.26+2.53 (+1.79%) ▲|COST987.72+9.71 (+0.99%) ▲|CRM241.89-4.85 (-1.97%) ▼|CSCO108.03-1.82 (-1.66%) ▼|CVS93.09+0.51 (+0.55%) ▲|CVX222.46+3.14 (+1.43%) ▲|DE649.95-0.73 (-0.11%) ▼|DHR229.74-1.76 (-0.76%) ▼|DIS111.50+0.82 (+0.74%) ▲|DUK120.54+1.66 (+1.39%) ▲|EMR162.67+0.52 (+0.32%) ▲|FDX297.57+2.03 (+0.69%) ▲|GD344.02+6.99 (+2.07%) ▲|GE319.62+7.62 (+2.44%) ▲|GEV933.59+7.15 (+0.77%) ▲|GILD156.90-0.47 (-0.30%) ▼|GM85.23+1.57 (+1.88%) ▲|GOOG340.26-4.65 (-1.35%) ▼|GOOGL344.13-5.09 (-1.46%) ▼|GS899.30+8.02 (+0.90%) ▲|HD312.61+4.37 (+1.42%) ▲|HON211.78+1.28 (+0.61%) ▲|IBM233.52-0.60 (-0.26%) ▼|INTC92.34-3.03 (-3.18%) ▼|INTU326.59-3.58 (-1.08%) ▼|ISRG433.29+5.43 (+1.27%) ▲|JNJ257.34+4.06 (+1.60%) ▲|JPM342.06+6.53 (+1.95%) ▲|KO93.37+1.37 (+1.48%) ▲|LIN500.24+7.02 (+1.42%) ▲|LLY1,265.23+13.62 (+1.09%) ▲|LMT546.01+13.37 (+2.51%) ▲|LOW198.43+2.71 (+1.38%) ▲|LRCX270.92-6.55 (-2.36%) ▼|MA620.09+3.77 (+0.61%) ▲|MCD243.80+1.30 (+0.53%) ▲|MDLZ64.06+1.03 (+1.63%) ▲|MDT95.63+0.18 (+0.19%) ▲|META726.33-10.39 (-1.41%) ▼|MMM167.05+1.72 (+1.04%) ▲|MO74.86+1.02 (+1.38%) ▲|MRK147.21+2.02 (+1.39%) ▲|MS182.90+0.80 (+0.44%) ▲|MSFT535.99-3.45 (-0.64%) ▼|MU893.37-37.87 (-4.07%) ▼|NEE80.08+1.12 (+1.42%) ▲|NFLX71.06-1.56 (-2.14%) ▼|NKE37.61+0.47 (+1.27%) ▲|NOW145.95-2.63 (-1.77%) ▼|NVDA216.23-1.00 (-0.46%) ▼|ORCL131.80-2.67 (-1.99%) ▼|PEP130.37+1.99 (+1.55%) ▲|PFE29.56+0.12 (+0.41%) ▲|PG159.63+2.55 (+1.62%) ▲|PLTR194.95-5.55 (-2.77%) ▼|PM204.33+4.43 (+2.21%) ▲|QCOM174.35-4.05 (-2.27%) ▼|RTX190.95+4.00 (+2.14%) ▲|SBUX97.01+0.13 (+0.13%) ▲|SCHW93.83-0.33 (-0.35%) ▼|SO90.12+0.94 (+1.05%) ▲|SPG205.58+2.19 (+1.08%) ▲|T23.56+0.06 (+0.23%) ▲|TMO691.51-4.98 (-0.72%) ▼|TMUS158.75+1.72 (+1.10%) ▲|TSLA366.61+4.17 (+1.15%) ▲|TXN280.91+1.79 (+0.64%) ▲|UBER71.22-0.05 (-0.07%) ▼|UNH397.50-9.17 (-2.25%) ▼|UNP289.48+0.77 (+0.27%) ▲|UPS99.15+1.32 (+1.35%) ▲|USB58.62+1.23 (+2.13%) ▲|V403.07+3.32 (+0.83%) ▲|VZ44.66+0.26 (+0.57%) ▲|WFC84.08+1.33 (+1.61%) ▲|WMT118.83+0.96 (+0.81%) ▲|XOM175.92+1.24 (+0.71%) ▲|AAPL343.75+1.75 (+0.51%) ▲|ABBV284.01+0.66 (+0.23%) ▲|ABT105.38+0.70 (+0.67%) ▲|ACN225.52+0.60 (+0.27%) ▲|ADBE249.76-1.91 (-0.76%) ▼|AMAT421.43-8.58 (-2.00%) ▼|AMD542.63-19.61 (-3.49%) ▼|AMGN437.85+3.82 (+0.88%) ▲|AMT183.39+2.03 (+1.12%) ▲|AMZN253.21-1.55 (-0.61%) ▼|AVGO338.43-5.91 (-1.71%) ▼|AXP319.10+5.23 (+1.67%) ▲|BA191.52+2.79 (+1.48%) ▲|BAC52.32+0.62 (+1.20%) ▲|BKNG166.32+0.52 (+0.31%) ▲|BLK1,139.18+18.40 (+1.64%) ▲|BMY60.81+0.24 (+0.39%) ▲|BNY143.80+1.71 (+1.20%) ▲|BRK-B531.42+5.74 (+1.09%) ▲|C125.85+2.64 (+2.14%) ▲|CAT738.06+2.42 (+0.33%) ▲|CL93.65+0.98 (+1.06%) ▲|CMCSA22.08+0.31 (+1.42%) ▲|COF203.55+4.69 (+2.36%) ▲|COP144.26+2.53 (+1.79%) ▲|COST987.72+9.71 (+0.99%) ▲|CRM241.89-4.85 (-1.97%) ▼|CSCO108.03-1.82 (-1.66%) ▼|CVS93.09+0.51 (+0.55%) ▲|CVX222.46+3.14 (+1.43%) ▲|DE649.95-0.73 (-0.11%) ▼|DHR229.74-1.76 (-0.76%) ▼|DIS111.50+0.82 (+0.74%) ▲|DUK120.54+1.66 (+1.39%) ▲|EMR162.67+0.52 (+0.32%) ▲|FDX297.57+2.03 (+0.69%) ▲|GD344.02+6.99 (+2.07%) ▲|GE319.62+7.62 (+2.44%) ▲|GEV933.59+7.15 (+0.77%) ▲|GILD156.90-0.47 (-0.30%) ▼|GM85.23+1.57 (+1.88%) ▲|GOOG340.26-4.65 (-1.35%) ▼|GOOGL344.13-5.09 (-1.46%) ▼|GS899.30+8.02 (+0.90%) ▲|HD312.61+4.37 (+1.42%) ▲|HON211.78+1.28 (+0.61%) ▲|IBM233.52-0.60 (-0.26%) ▼|INTC92.34-3.03 (-3.18%) ▼|INTU326.59-3.58 (-1.08%) ▼|ISRG433.29+5.43 (+1.27%) ▲|JNJ257.34+4.06 (+1.60%) ▲|JPM342.06+6.53 (+1.95%) ▲|KO93.37+1.37 (+1.48%) ▲|LIN500.24+7.02 (+1.42%) ▲|LLY1,265.23+13.62 (+1.09%) ▲|LMT546.01+13.37 (+2.51%) ▲|LOW198.43+2.71 (+1.38%) ▲|LRCX270.92-6.55 (-2.36%) ▼|MA620.09+3.77 (+0.61%) ▲|MCD243.80+1.30 (+0.53%) ▲|MDLZ64.06+1.03 (+1.63%) ▲|MDT95.63+0.18 (+0.19%) ▲|META726.33-10.39 (-1.41%) ▼|MMM167.05+1.72 (+1.04%) ▲|MO74.86+1.02 (+1.38%) ▲|MRK147.21+2.02 (+1.39%) ▲|MS182.90+0.80 (+0.44%) ▲|MSFT535.99-3.45 (-0.64%) ▼|MU893.37-37.87 (-4.07%) ▼|NEE80.08+1.12 (+1.42%) ▲|NFLX71.06-1.56 (-2.14%) ▼|NKE37.61+0.47 (+1.27%) ▲|NOW145.95-2.63 (-1.77%) ▼|NVDA216.23-1.00 (-0.46%) ▼|ORCL131.80-2.67 (-1.99%) ▼|PEP130.37+1.99 (+1.55%) ▲|PFE29.56+0.12 (+0.41%) ▲|PG159.63+2.55 (+1.62%) ▲|PLTR194.95-5.55 (-2.77%) ▼|PM204.33+4.43 (+2.21%) ▲|QCOM174.35-4.05 (-2.27%) ▼|RTX190.95+4.00 (+2.14%) ▲|SBUX97.01+0.13 (+0.13%) ▲|SCHW93.83-0.33 (-0.35%) ▼|SO90.12+0.94 (+1.05%) ▲|SPG205.58+2.19 (+1.08%) ▲|T23.56+0.06 (+0.23%) ▲|TMO691.51-4.98 (-0.72%) ▼|TMUS158.75+1.72 (+1.10%) ▲|TSLA366.61+4.17 (+1.15%) ▲|TXN280.91+1.79 (+0.64%) ▲|UBER71.22-0.05 (-0.07%) ▼|UNH397.50-9.17 (-2.25%) ▼|UNP289.48+0.77 (+0.27%) ▲|UPS99.15+1.32 (+1.35%) ▲|USB58.62+1.23 (+2.13%) ▲|V403.07+3.32 (+0.83%) ▲|VZ44.66+0.26 (+0.57%) ▲|WFC84.08+1.33 (+1.61%) ▲|WMT118.83+0.96 (+0.81%) ▲|XOM175.92+1.24 (+0.71%) ▲|
17.3 C
New York
Friday, October 16, 2026

Tag: cancer

Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn’s Disease and Ulcerative Colitis at ACG 2026

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely...

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026

MILAN, Oct. 10, 2026 /PRNewswire/ -- From October 06 to 08, 2026, Kexing Biopharm (688136.SH) exhibited at CPHI Milan 2026, showcasing its global innovative drug...

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026

MILAN, Oct. 10, 2026 /PRNewswire/ -- From October 06 to 08, 2026, Kexing Biopharm (688136.SH) exhibited at CPHI Milan 2026, showcasing its global innovative drug...

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026

MILAN, Oct. 10, 2026 /CNW/ -- From October 06 to 08, 2026, Kexing Biopharm (688136.SH) exhibited at CPHI Milan 2026, showcasing its global innovative drug...

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026

MILAN, Oct. 10, 2026 /PRNewswire/ -- From October 06 to 08, 2026, Kexing Biopharm (688136.SH) exhibited at CPHI Milan 2026, showcasing its global innovative drug...

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a...

Hyundai Hope on Wheels makes $200,000 donation to bolster the fight against childhood cancer in Quebec

The Foundation CHUS Sherbrooke and the Montreal Children's Hospital Foundation received $100,000 each from the Hyundai Hope on Wheels.The grants, presented during two inspiring...

Blood Cancer United Presents Inaugural Breakthrough Voice and Breakthrough Rising Leader Awards at First-Ever Night of Champions

Dr. Siddhartha Mukherjee and Charlotte Nathanson honored during Blood Cancer United's Breakthroughs Summit in New York CityNEW YORK, Oct. 9, 2026 /PRNewswire/ -- Blood Cancer...

WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

JERSEY CITY, N.J., Oct. 9, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that bioAffinity Technologies,...

ALF’s Liver Life Challenge is Official Charity Partner of 2026 Bank of America Chicago Marathon

Team ALF Chicago Marathon runners unite to fight liver disease CHICAGO, Oct. 9, 2026 /PRNewswire/ -- American Liver Foundation (ALF) is proud to once again be...

Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026

SHANGHAI and HONG KONG, Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026

SHANGHAI and HONG KONG, Oct. 8, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead,...

Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development

Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCancer